Differential Shear Forces on Endocardial Endothelial Cells Regulate a Fibrotic Spectrum in the Left Ventricular Outflow Tract
心内膜内皮细胞上的差异剪切力调节左心室流出道中的纤维化谱
基本信息
- 批准号:10170409
- 负责人:
- 金额:$ 52.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAnatomyAnesthesia proceduresAutomobile DrivingBackBioreactorsBlood flowCardiacCardiopulmonary BypassCardiovascular DiseasesCell CommunicationCellsCharacteristicsChildChild CareClinicalComplexComputer ModelsCounselingCytokine SignalingDataDiscrete Subaortic StenosisDiseaseEndothelial CellsEndotheliumEnvironmentExcisionExposure toExtracellular MatrixFibroblastsFibrosisFunctional disorderGeometryGrowthHeartHumanImmuneInflammationInflammatoryInflammatory ResponseKnowledgeLeftLesionLiquid substanceMediatingMembraneMesenchymalModelingMorbidity - disease rateNatural HistoryObstructionOperative Surgical ProceduresOrganPathogenesisPathologic ProcessesPatientsPatternPhenotypePreventionProceduresProteomicsQuality of lifeRecurrenceRepeat SurgeryRoleSignal TransductionSternotomySystemTestingTissuesTranslatingVascular Endothelial CellVentricularaortic valvecellular transductioncongenital heart disordercostdata modelingdynamic systemfollow-upheart functionimprovedinflammatory milieuinnovationinsightmechanical forcemechanotransductionpredictive modelingpressureprognostic modelresponseshear stresstheoriestool
项目摘要
PROJECT SUMMARY
Discrete subaortic stenosis (DSS) is a congenital or acquired condition that accounts for ~10% of all
cases of left ventricular outflow tract (LVOT) obstruction, and is characterized by a ring of fibrous tissue
below the aortic valve. Current treatment is surgical removal of the obstruction, but the unpredictable
recurrence and progression of DSS leads to multiple repeat surgeries and attendant morbidity into
adulthood. Current theories postulate that altered LVOT geometry causes increased shear stress and
ultimately fibrosis in DSS; however, little is known about the mechanism of DSS progression. Studies in
vascular endothelial cells demonstrated increased inflammation and phenotypic changes in response to
altered shear forces, but effects of shear are under-studied in endocardial endothelial cells (EEC).
Additionally, resident fibroblasts are implicated in organ fibrosis, including cardiac tissue, in response to
altered cytokine signaling and mechanical forces. We hypothesize that that altered shear forces induce
an inflammatory response by EEC, which interacts with cardiac fibroblasts (CF) to govern a fibrotic
phenotype that contributes to the pathophysiology of DSS, which we will address with three specific aims.
AIM 1. Elucidate the mechanisms of how shear forces regulate EEC inflammatory phenotype.First, we
shall utilize patient echo data and computational modeling to develop a bioreactor that resembles altered flows
in DSS. Using this innovative system, we will then test the role of CD-31 mechanosensory signaling in EEC in
response to altered shear forces and geometry. Lastly, we shall investigate the effects of altered shear forces
on EEC interactions with inflammatory cells in propagating a pro-inflammatory environment.
AIM 2. Determine EEC transduction of altered shear forces to govern fibrosis in the LVOT. We shall
investigate EEC propensity towards endoMT in response to simulated DSS altered shear and immune
cell interactions. We shall then investigate the direct and inflammatory-mediated effects of EEC
mechanosensing on CF that produce a fibrotic ECM. Lastly, we shall study the effect of the stiffer
environment induced by fibrosis on EEC-CF crosstalk, which may propagate the fibrotic response.
AIM 3. Characterize the aggressive DSS phenotype using patient data to develop a predictive model. We
shall first evaluate the ECM composition, remodeling profile and echo data that characterizes the aggressive
forms of DSS in humans. We shall then use these data to develop a multivariate computational model that can
be used to predict an aggressive phenotype, which will be validated and tested.
This proposal will improve the care of children with DSS. With completion of these aims, innovative
tools and new knowledge will emerge about the effects of shear force on EEC-CF and EEC-immune cell
cross-talk. These findings have potential implications for any cardiovascular disease with altered flow
associated with fibrosis.
项目摘要
离散性主动脉瓣下狭窄(DSS)是一种先天性或后天性疾病,占所有
例左心室流出道(LVOT)梗阻,其特征为纤维组织环
在主动脉瓣下目前的治疗方法是手术切除梗阻,但不可预测的
DSS的复发和进展导致多次重复手术和伴随的发病率,
成年目前的理论假设,改变LVOT几何形状会导致剪切应力增加,
最终导致DSS中的纤维化;然而,关于DSS进展的机制知之甚少。研究
血管内皮细胞表现出增加的炎症和表型变化,
改变的剪切力,但在内皮细胞(EEC)中剪切的影响研究不足。
此外,常驻成纤维细胞参与器官纤维化,包括心脏组织,以响应于
改变细胞因子信号和机械力。我们假设改变的剪切力
EEC的炎症反应,其与心脏成纤维细胞(CF)相互作用以控制纤维化
表型,有助于DSS的病理生理学,我们将解决三个具体目标。
AIM 1.阐明剪切力如何调节EEC炎症表型的机制。
应利用患者回波数据和计算建模来开发类似于改变的流动的生物反应器
在DSS。使用这个创新的系统,我们将测试CD-31机械感觉信号在EEC中的作用,
对改变的剪切力和几何形状的响应。最后,我们将研究改变剪切力的影响
在传播促炎环境中与炎性细胞的EEC相互作用。
AIM 2.确定改变的剪切力的EEC转换以控制LVOT中的纤维化。我们将
研究响应于模拟DSS改变剪切和免疫的EEC对endoMT的倾向
细胞相互作用然后,我们将研究EEC的直接和炎症介导的作用
在CF上的机械感测产生纤维化ECM。最后,我们将研究更硬的
纤维化诱导的环境对EEC-CF串扰的影响,这可能传播纤维化反应。
AIM 3.使用患者数据表征侵袭性DSS表型以开发预测模型。我们
应首先评估ECM组成,重塑轮廓和回声数据,表征侵略性
人类的DSS形式。然后,我们将使用这些数据来开发一个多变量计算模型,
用于预测侵袭性表型,这将得到验证和测试。
这项建议将改善对直接资助计划儿童的照顾。随着这些目标的实现,创新
剪切力对内皮细胞-CF和内皮细胞-免疫细胞的影响将出现新的工具和知识
串话这些发现对任何血流改变的心血管疾病都有潜在的意义
与纤维化有关。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Discrete Subaortic Stenosis: Perspective Roadmap to a Complex Disease.
- DOI:10.3389/fcvm.2018.00122
- 发表时间:2018
- 期刊:
- 影响因子:3.6
- 作者:Massé DD;Shar JA;Brown KN;Keswani SG;Grande-Allen KJ;Sucosky P
- 通讯作者:Sucosky P
Computational Assessment of Valvular Dysfunction in Discrete Subaortic Stenosis: A Parametric Study.
- DOI:10.1007/s13239-020-00513-8
- 发表时间:2021-12
- 期刊:
- 影响因子:1.8
- 作者:Shar JA;Keswani SG;Grande-Allen KJ;Sucosky P
- 通讯作者:Sucosky P
Congenital Heart Disease: An Immunological Perspective.
- DOI:10.3389/fcvm.2021.701375
- 发表时间:2021
- 期刊:
- 影响因子:3.6
- 作者:Singampalli KL;Jui E;Shani K;Ning Y;Connell JP;Birla RK;Bollyky PL;Caldarone CA;Keswani SG;Grande-Allen KJ
- 通讯作者:Grande-Allen KJ
The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease.
- DOI:10.3389/fcvm.2021.701224
- 发表时间:2021
- 期刊:
- 影响因子:3.6
- 作者:Jui E;Singampalli KL;Shani K;Ning Y;Connell JP;Birla RK;Bollyky PL;Caldarone CA;Keswani SG;Grande-Allen KJ
- 通讯作者:Grande-Allen KJ
Significance of aortoseptal angle anomalies to left ventricular hemodynamics and subaortic stenosis: A numerical study.
主动脉膜角度异常对左心室血流动力学和亚电狭窄的意义:一项数值研究。
- DOI:10.1016/j.compbiomed.2022.105613
- 发表时间:2022-07
- 期刊:
- 影响因子:7.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHRYN JANE GRANDE-ALLEN其他文献
KATHRYN JANE GRANDE-ALLEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHRYN JANE GRANDE-ALLEN', 18)}}的其他基金
Biomaterial Strategies for Tissue Engineering Pediatric Valves
组织工程儿科瓣膜的生物材料策略
- 批准号:
8315987 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Tissue Engineering Strategies: Effects on Valvular Interstitial Cell Metabolism
组织工程策略:对瓣膜间质细胞代谢的影响
- 批准号:
8241919 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Biomimetic micro-structured hydrogel scaffolds for tissue engineered heart valves
用于组织工程心脏瓣膜的仿生微结构水凝胶支架
- 批准号:
8663737 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Biomimetic micro-structured hydrogel scaffolds for tissue engineered heart valves
用于组织工程心脏瓣膜的仿生微结构水凝胶支架
- 批准号:
8250357 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Tissue Engineering Strategies: Effects on Valvular Interstitial Cell Metabolism
组织工程策略:对瓣膜间质细胞代谢的影响
- 批准号:
8113636 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Biomaterial Strategies for Tissue Engineering Pediatric Valves
组织工程儿科瓣膜的生物材料策略
- 批准号:
8178833 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
Biomimetic micro-structured hydrogel scaffolds for tissue engineered heart valves
用于组织工程心脏瓣膜的仿生微结构水凝胶支架
- 批准号:
8086246 - 财政年份:2011
- 资助金额:
$ 52.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 52.07万 - 项目类别:
Research Grant














{{item.name}}会员




